Home HDAC1 triggers the proliferation and migration of breast cancer cells via upregulation of interleukin-8
Article
Licensed
Unlicensed Requires Authentication

HDAC1 triggers the proliferation and migration of breast cancer cells via upregulation of interleukin-8

  • Zhaohui Tang , Sijuan Ding EMAIL logo , Honglin Huang , Pengfei Luo , Bohua Qing , Siyuan Zhang and Ruoting Tang
Published/Copyright: August 5, 2017

Abstract

Targeted inhibition of histone deacetylase (HDAC) is one of the potent anticancer therapy approaches. Our data showed that mRNA and protein levels of HDAC1 in breast cancer cells were greater than that in normal fibroblast 3T3 cells and normal epithelial breast MCF10A cells. The mRNA levels of HDAC1 in 75% of breast cancer tissues (18/24) were greater than that in their corresponding adjacent normal tissues. Knockdown of HDAC1 by specific siRNAs can suppress the proliferation and migration of breast cancer cells and inhibit the expression of interleukin-8 (IL-8), while not IL-6. While recombinant IL-8 (rIL-8) can attenuate the suppression effects of si-HDAC1 on the proliferation and migration of breast cancer cells. HDAC1 can positively regulate the transcription and promoter activities of IL-8. While NF-κB and MAPK, two important signals responsible for the transcription of IL-8, did not mediate HDAC1 regulated IL-8 expression. The expression and nuclear translocation of Snail were increased in HDAC1 over expressed breast cancer cells. Targeted inhibition of Snail can attenuate HDAC1 over expression induced cell proliferation and migration. Collectively, our data showed that HDAC1 can trigger the proliferation and migration of breast cancer cells via activation of Snail/IL-8 signals.

  1. Conflict of interest statement: The authors declare no conflict of interest.

References

Chen, Z.-J., Wei, W., Jiang, G.-M., Liu, H., Wei, W.-D., Yang, X., Wu, Y.-M., Liu, H., Wong, C.K., Du, J., et al. (2016). Activation of GPER suppresses epithelial mesenchymal transition of triple negative breast cancer cells via NF-κB signals. Mol. Oncol. 10, 775–788.10.1016/j.molonc.2016.01.002Search in Google Scholar PubMed PubMed Central

Choi, J.-H., Kwon, H.J., Yoon, B.-I., Kim, J.-H., Han, S.U., Joo, H.J., and Kim, D.-Y. (2001). Expression profile of histone deacetylase 1 in gastric cancer tissues. Jpn. J. Cancer Res. 92, 1300–1304.10.1111/j.1349-7006.2001.tb02153.xSearch in Google Scholar PubMed PubMed Central

Choi, S.W., Gatza, E., Hou, G., Sun, Y., Whitfield, J., Song, Y., Oravecz-Wilson, K., Tawara, I., Dinarello, C.A., and Reddy, P. (2015). Histone deacetylase inhibition regulates inflammation and enhances Tregs after allogeneic hematopoietic cell transplantation in humans. Blood 125, 815–819.10.1182/blood-2014-10-605238Search in Google Scholar PubMed PubMed Central

Connolly, R. and Stearns, V. (2012). Epigenetics as a therapeutic target in breast cancer. J. Mammary Gland Biol. Neoplasia 17, 191–204.10.1007/s10911-012-9263-3Search in Google Scholar PubMed PubMed Central

Eom, M., Oh, S.S., Lkhagvadorj, S., Han, A., and Park, K.H. (2012). HDAC1 expression in invasive ductal carcinoma of the breast and its value as a good prognostic factor. Korean J. Pathol. 46, 311–317.10.4132/KoreanJPathol.2012.46.4.311Search in Google Scholar PubMed PubMed Central

Halkidou, K., Gaughan, L., Cook, S., Leung, H.Y., Neal, D.E., and Robson, C.N. (2004). Upregulation and nuclear recruitment of HDAC1 in hormone refractory prostate cancer. Prostate 59, 177–189.10.1002/pros.20022Search in Google Scholar PubMed

Hartman, Z.C., Poage, G.M., den Hollander, P., Tsimelzon, A., Hill, J., Panupinthu, N., Zhang, Y., Mazumdar, A., Hilsenbeck, S.G., Mills, G.B., et al. (2013). Growth of triple-negative breast cancer cells relies upon coordinate autocrine expression of the proinflammatory cytokines IL-6 and IL-8. Cancer Res. 73, 3470–3480.10.1158/0008-5472.CAN-12-4524-TSearch in Google Scholar PubMed PubMed Central

He, W., Qu, T., Yu, Q., Wang, Z., Lv, H., Zhang, J., Zhao, X., and Wang, P. (2013). LPS induces IL-8 expression through TLR4, MyD88, NF-κB and MAPK pathways in human dental pulp stem cells. Int. Endod. J. 46, 128–136.10.1111/j.1365-2591.2012.02096.xSearch in Google Scholar PubMed

Hoshimoto, A., Suzuki, Y., Katsuno, T., Nakajima, H., and Saito, Y. (2002). Caprylic acid and medium-chain triglycerides inhibit IL-8 gene transcription in Caco-2 cells: comparison with the potent histone deacetylase inhibitor trichostatin A. Br. J. Pharmacol. 136, 280–286.10.1038/sj.bjp.0704719Search in Google Scholar PubMed PubMed Central

Hrab, M., Olek-Hrab, K., Antczak, A., Kwias, Z., and Milecki, T. (2013). Interleukin-6 (IL-6) and C-reactive protein (CRP) concentration prior to total nephrectomy are prognostic factors in localized renal cell carcinoma (RCC). Rep. Pract. Oncol. Radiother. 18, 304–309.10.1016/j.rpor.2013.06.002Search in Google Scholar PubMed PubMed Central

Hwang, W.-L., Yang, M.-H., Tsai, M.-L., Lan, H.-Y., Su, S.-H., Chang, S.-C., Teng, H.-W., Yang, S.-H., Lan, Y.T., Chiou, S.H., et al. (2011). SNAIL regulates interleukin-8 expression, stem cell-like activity, and tumorigenicity of human colorectal carcinoma cells. Gastroenterology 141, 279–291. e5.10.1053/j.gastro.2011.04.008Search in Google Scholar PubMed

Kanamoto, A., Ninomiya, I., Harada, S., Tsukada, T., Okamoto, K., Nakanuma, S., Sakai, S., Makino, I., Kinoshita, J., Hayashi, H., et al. (2016). Valproic acid inhibits irradiation-induced epithelial-mesenchymal transition and stem cell-like characteristics in esophageal squamous cell carcinoma. Int. J. Oncol. 49, 1859–1869.10.3892/ijo.2016.3712Search in Google Scholar PubMed PubMed Central

Kawai, H., Li, H., Avraham, S., Jiang, S., and Avraham, H.K. (2003). Overexpression of histone deacetylase HDAC1 modulates breast cancer progression by negative regulation of estrogen receptor α. Int. J. Cancer 107, 353–358.10.1002/ijc.11403Search in Google Scholar PubMed

Kim, N.H., Kim, H.S., Li, X.-Y., Lee, I., Choi, H.-S., Kang, S.E., Cha, S.Y., Ryu, J.K., Yoon, D., Fearon, E.R., et al. (2011). A p53/miRNA-34 axis regulates Snail1-dependent cancer cell epithelial–mesenchymal transition. J. Cell Biol. 195, 417–433.10.1083/jcb.201103097Search in Google Scholar PubMed PubMed Central

Li, L., Chen, L., Zhang, W., Liao, Y., Chen, J., Shi, Y., and Luo, S. (2017). Serum cytokine profile in patients with breast cancer. Cytokine 89, 173–178.10.1016/j.cyto.2015.12.017Search in Google Scholar PubMed

Lyons, J.G., Patel, V., Roue, N.C., Fok, S.Y., Soon, L.L., Halliday, G.M., and Gutkind, J.S. (2008). Snail up-regulates proinflammatory mediators and inhibits differentiation in oral keratinocytes. Cancer Res. 68, 4525–4530.10.1158/1078-0432.CCR-07-6735Search in Google Scholar PubMed PubMed Central

New, M., Olzscha, H., and La Thangue, N.B. (2012). HDAC inhibitor-based therapies: can we interpret the code? Mol. Oncol. 6, 637–656.10.1016/j.molonc.2012.09.003Search in Google Scholar PubMed PubMed Central

Pang, X., Li, K., Wei, L., Huang, Y., Su, M., Wang, L., Cao, H., and Chen, T. (2015). [IL-8 inhibits the apoptosis of MCF-7 human breast cancer cells by up-regulating Bcl-2 and down-regulating caspase-3]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi (in Chinese) 31, 307–311.Search in Google Scholar

Park, S.Y., Jun, J.A., Jeong, K.J., Heo, H.J., Sohn, J.S., Lee, H.Y., Park, C.G., and Kang, J. (2011). Histone deacetylases 1, 6 and 8 are critical for invasion in breast cancer. Oncol. Rep. 25, 1677–1681.10.3892/or.2011.1236Search in Google Scholar PubMed

Peinado, H., Ballestar, E., Esteller, M., and Cano, A. (2004). Snail mediates E-cadherin repression by the recruitment of the Sin3A/histone deacetylase 1 (HDAC1)/HDAC2 complex. Mol. Cell. Biol. 24, 306–319.10.1128/MCB.24.1.306-319.2004Search in Google Scholar PubMed PubMed Central

Phuagkhaopong, S., Ospondpant, D., Kasemsuk, T., Sibmooh, N., Soodvilai, S., Power, C., and Vivithanaporn, P. (2017). Cadmium-induced IL-6 and IL-8 expression and release from astrocytes are mediated by MAPK and NF-κB pathways. NeuroToxicology 60, 82–91.10.1016/j.neuro.2017.03.001Search in Google Scholar PubMed

Sasaki, H., Moriyama, S., Nakashima, Y., Kobayashi, Y., Kiriyama, M., Fukai, I., Yamakawa, Y., and Fujii, Y. (2004). Histone deacetylase 1 mRNA expression in lung cancer. Lung Cancer Amst. Neth. 46, 171–178.10.1016/j.lungcan.2004.03.021Search in Google Scholar PubMed

Senese, S., Zaragoza, K., Minardi, S., Muradore, I., Ronzoni, S., Passafaro, A., Bernard, L., Draetta, G.F., Alcalay, M., Seiser, C., et al. (2007). Role for histone deacetylase 1 in human tumor cell proliferation. Mol. Cell. Biol. 27, 4784–4795.10.1128/MCB.00494-07Search in Google Scholar PubMed PubMed Central

Siegel, R.L., Miller, K.D., and Jemal, A. (2015). Cancer statistics, 2015. CA. Cancer J. Clin. 65, 5–29.10.3322/caac.21254Search in Google Scholar PubMed

Singh, J.K., Simões, B.M., Howell, S.J., Farnie, G., and Clarke, R.B. (2013). Recent advances reveal IL-8 signaling as a potential key to targeting breast cancer stem cells. Breast Cancer Res. 15, 210.10.1186/bcr3436Search in Google Scholar PubMed PubMed Central

Smith, K.T., and Workman, J.L. (2009). Histone deacetylase inhibitors: anticancer compounds. Int. J. Biochem. Cell Biol. 41, 21–25.10.1016/j.biocel.2008.09.008Search in Google Scholar PubMed

Weichert, W. (2009). HDAC expression and clinical prognosis in human malignancies. Cancer Lett. 280, 168–176.10.1016/j.canlet.2008.10.047Search in Google Scholar PubMed

West, A.C., and Johnstone, R.W. (2014). New and emerging HDAC inhibitors for cancer treatment. J. Clin. Invest. 124, 30–39.10.1172/JCI69738Search in Google Scholar PubMed PubMed Central

Witt, A.E., Lee, C.-W., Lee, T.I., Azzam, D.J., Wang, B., Caslini, C., Petrocca, F., Grosso, J., Jones, M., Cohick, E.B., et al. (2017). Identification of a cancer stem cell-specific function for the histone deacetylases, HDAC1 and HDAC7, in breast and ovarian cancer. Oncogene 36, 1707–1720.10.1038/onc.2016.337Search in Google Scholar PubMed PubMed Central

Xiao, W., Chen, X., Liu, X., Luo, L., Ye, S., and Liu, Y. (2014). Trichostatin A, a histone deacetylase inhibitor, suppresses proliferation and epithelial-mesenchymal transition in retinal pigment epithelium cells. J. Cell. Mol. Med. 18, 646–655.10.1111/jcmm.12212Search in Google Scholar PubMed PubMed Central

Zhang, Z., Yamashita, H., Toyama, T., Sugiura, H., Ando, Y., Mita, K., Hamaguchi, M., Hara, Y., Kobayashi, S., and Iwase, H. (2005). Quantitation of HDAC1 mRNA expression in invasive carcinoma of the breast. Breast Cancer Res. Treat. 94, 11–16.10.1007/s10549-005-6001-1Search in Google Scholar PubMed

Received: 2017-5-4
Accepted: 2017-8-1
Published Online: 2017-8-5
Published in Print: 2017-11-27

©2017 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 1.10.2025 from https://www.degruyterbrill.com/document/doi/10.1515/hsz-2017-0155/html
Scroll to top button